Ligand validation:6JBT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6JBT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JBT_NAG_F_307	11%	81%	0.283	0.801	0.42	0.4	-	-	0	0	100%	0.9333
6JJP_NAG_C_306	43%	78%	0.144	0.867	0.34	0.54	-	-	0	0	100%	0.9333
6J15_NAG_C_301	27%	71%	0.166	0.809	0.46	0.64	-	-	0	0	100%	0.9333
8U32_NAG_D_201	21%	60%	0.224	0.834	0.55	0.96	-	1	0	0	100%	0.9333
8AS0_NAG_O_201	21%	86%	0.205	0.812	0.22	0.49	-	-	0	0	100%	0.9333
7CGW_NAG_P_203	18%	71%	0.246	0.83	0.31	0.8	-	-	6	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.